SMAD3 and neoplasm: In line with our previous observations, the only organoid showing no changes in viability lacked a functional canonical TGF-β signalling with no SMAD3 phosphorylation, corroborating that TGF-β signalling inhibition promotes tumour cell growth only when SMAD canonical signalling is properly functional.